Nexicon Pharmaceuticals Private Limited
About Nexicon Pharmaceuticals Private Limited
Data last updated:
Nexicon Pharmaceuticals Private Limited is a private limited company based in Nashik, Maharashtra, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 27 April 2022.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U85300MH2022PTC381586.
The company has an authorised share capital of ₹15 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Yogesh Dinesh Nemade and Chetan Yashwant Rane.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Office No 02 Shri Hari Residency Plot No 119 Sr No 297/2/1 Pathardi Shivar, Nashik, Maharashtra, India – 422010.
As per the financials filed for FY 2024, the company reported a revenue of ₹6.83 Cr, a growth of 115% compared to the previous year. For the same year it recorded a net profit of ₹34.83 Lakh (net margin 5.1%) and EBITDA of ₹49.48 Lakh (EBITDA margin 7.2%).
As per MCA filings, the company has open charges of ₹1.86 Cr on record.
Company details
Contact details
Nexicon Pharmaceuticals Private Limited's registered office is in Nashik, Maharashtra.
- Registered AddressOffice No 02 Shri Hari Residency Plot No 119 Sr No 297/2/1 Pathardi Shivar, Nashik, Maharashtra, India – 422010
- IndustryPharma, Drug Formulation & Development
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Nexicon Pharmaceuticals is hospital and medical care. In detail, this covers other hospital and medical care activities.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| Q | Hospital and Medical Care | Q6 | Other Hospital and Medical Care Activities |
To see the full business activity and turnover split of Nexicon Pharmaceuticals Private Limited, buy the company report.
Financials of Nexicon Pharmaceuticals Private Limited
FY 2025 filings availableNexicon Pharmaceuticals Private Limited reported revenue of ₹6.83 Cr (up 115% YoY) for FY 2024.
Compounded Annual Growth Rate (CAGR)
Revenue rose 115% in the latest year. EBITDA rose 127% in the latest year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2023-24 | FY 2022-23 |
|---|---|---|
| Profit and Loss Statement | ||
| Revenue from Operations | ||
| Other Income | ||
| Total Revenue | ||
| Cost of Materials Consumed | ||
| Employee Benefit Expense | ||
| Finance Costs | ||
| Depreciation and Amortisation | ||
| Other Expenses | ||
| Total Expenses | ||
| EBITDA | ₹49.48 Lakh | |
| Profit Before Tax | ||
| Tax Expense | ||
| Net Profit (PAT) | ₹34.83 Lakh | |
| Balance Sheet | ||
| Share Capital | ||
| Reserves and Surplus | ||
| Net Worth (Total Equity) | ||
| Long-term Borrowings | ||
| Short-term Borrowings | ||
| Trade Payables | ||
| Total Liabilities | ||
| Fixed Assets | ||
| Investments | ||
| Inventories | ||
| Trade Receivables | ||
| Cash and Bank Balance | ||
| Total Assets | ||
Financial Ratios
| Metrics | FY 2023-24 | FY 2022-23 |
|---|---|---|
| Profitability | ||
| EBITDA Margin | 7.2% | |
| Net Profit Margin | 5.1% | |
| Return on Equity (ROE) | ||
| Return on Capital Employed (ROCE) | ||
| Return on Assets (ROA) | ||
| Liquidity and Debt | ||
| Current Ratio | ||
| Quick Ratio | ||
| Debt-to-Equity Ratio | ||
| Interest Coverage Ratio | ||
| Efficiency and Growth | ||
| Asset Turnover | ||
| Receivable Days | ||
| Payable Days | ||
| Inventory Days | ||
| Revenue Growth | ||
| Net Profit Growth | ||
To see the full financial statements and ratios of Nexicon Pharmaceuticals Private Limited, buy the company report.
Board of directors of Nexicon Pharmaceuticals Private Limited
Nexicon Pharmaceuticals has 2 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Yogesh Dinesh Nemade Also directs: Nexreet Ceutics Private Limited | Director | 27 Apr 2022 | 4 Years 6 Months | Current |
| Chetan Yashwant Rane | Director | 27 Apr 2022 | 4 Years 6 Months | Current |
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 30 Apr 2025 | 101112678 | Others | ₹1.86 Cr | Open |
Total charge records: 1 View all charges
Legal cases
No court or tribunal cases involving Nexicon Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Nexicon Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
No GST registration is on our record for Nexicon Pharmaceuticals Private Limited; the GSTIN and return-filing check is in the company report Buy the company report.
Recent activity
Nexicon Pharmaceuticals Private Limited has 2 board changes on record since 2022: 2 appointments. The latest: Chetan Yashwant Rane was appointed as Director on 27 Apr 2022.
Frequently asked questions
Nexicon Pharmaceuticals is an active private limited company based in Nashik, Maharashtra, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 27 April 2022 (4+ years old) and is registered under CIN U85300MH2022PTC381586.
Nexicon Pharmaceuticals has 2 current directors:
- Yogesh Dinesh Nemade - Director
- Chetan Yashwant Rane - Director
The latest financial statements of Nexicon Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2023 are in the company report.
The CIN (Corporate Identification Number) of Nexicon Pharmaceuticals is U85300MH2022PTC381586. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Nexicon Pharmaceuticals was incorporated on 27 April 2022, making it 4+ years old. It is registered with the Registrar of Companies, Mumbai.
Chetan Yashwant Rane was appointed as Director on 27 Apr 2022. Yogesh Dinesh Nemade was appointed as Director on 27 Apr 2022.
The registered office of Nexicon Pharmaceuticals is at Office No 02 Shri Hari Residency Plot No 119 Sr No 29721 Pathardi Shivar, Nashik, Maharashtra, India – 422010.
Nexicon Pharmaceuticals operates in the pharma industry, in the drug formulation and development segment.
Nexicon Pharmaceuticals has open charges of ₹1.86 Cr and no satisfied charges on record as per latest MCA filings.
Nexicon Pharmaceuticals can be reached at its registered office: Office No 02 Shri Hari Residency Plot No 119 Sr No 29721 Pathardi Shivar, Nashik, Maharashtra, India – 422010.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
